Ledger.Open graph →

SEC Form D · filed November 24, 2025

Jaguar Health, Inc

Offering

$10.8M

Sold

$10.8M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

San Francisco, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Pravin Chaturvedi · San Francisco, CAExec Lisa Conte · San Francisco, CAExec · Director Carol Lizak · San Francisco, CAExec Kelly Dulong · Seattle, WADirector Carol Lizak · San Francisco, CAExec Gregory Bradley · Seattle, WAExec Alan Okagaki · Seattle, WAExec John Micek Iii · San Francisco, CADirector Aman Jeloka · Seattle, WADirector James Bochnowski · San Francisco, CADirector Jonathan Wolin · San Francisco, CAExec Mary Houghton · Seattle, WADirector John Micek Iii · San Francisco, CADirector Sue Taoka · Seattle, WAExec · Director Lee Winslett · Seattle, WADirector Bruce Brooks · Seattle, WAExec Anula Jayasuriya · San Francisco, CADirector Jonathan Wolin · San Francisco, CAExec Jonathan Siegel · San Francisco, CADirector Lisa Conte · San Francisco, CAExec · Director Steven King · San Francisco, CAExec Pravin Chaturvedi · San Francisco, CAExec Norma Hernandez · Seattle, WAExec James Bochnowski · San Francisco, CADirector Anula Jayasuriya · San Francisco, CADirector Jonathan Siegel · San Francisco, CADirector Steven King · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗